Culturally Adapted Contingency Management

Part of paid clinical trials in New Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT07443332
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Stimulant Use Disorders

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Cultually Adapted Contingency Management (CM) — BEHAVIORAL
    Same protocol as basic CM with adaptations incorporated. The adaption will involve the ADAPT-ITT framework and PEN-3 cultural model.
  • Basic Contingency Management (CM) — BEHAVIORAL
    An escalating schedule of reinforcement for submitting stimulant-negative urine at each clinic visit over the course of the 12 weeks

Study Details

The purpose of this study is to develop a culturally adapted contingency management (CM) protocol for Black adults with stimulant use disorder.

Key Dates

Start date
Mar 31, 2026
Status verified
Feb 2026
Primary completion
Mar 31, 2030
Completion
Mar 31, 2030

Study Design

Enrollment
70 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Culturally Adapted CM
    Participants in this arm will receive the culturally adapted CM over a 12- week treatment period
  • Experimental: Basic CM
    Participants in this arm will receive the basic CM over a 12- week treatment period
  • No Intervention: Standard Care Condition
    Intensive Outpatient clinic (IOP) at substance use treatment and addiction (SATU) clinic twice every week, one day for group and the other for individual counseling

Primary Outcome Measure

Percent negative urine samples [ Time Frame: Week 12 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Connecticut Mental Health Center (CMHC)New HavenConnecticut06519-

Find similar trials in New Haven, CT

Related Studies